Our manuscript providing structural and computational basis of interactions between human glutamate carboxypeptidase II and carbamate-based inhibitors has been accepted to Bioorganic Medicinal Chemistry Here we show that in addition to the binding free energy in protein–ligand interaction  a broader range of factors  including strain and solvation/desolvation energy  need to be taken into account in predicting ligand-protein binding affinity